EP2483255
Oxasínafleiður og notkun þeirra við að meðhöndla taugaraskanir
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
13.7.2011EP published:
16.10.2013EP application number:
11806295.9
EP translation filed:
6.1.2014Grant published:
15.1.2014EPO information:
European Patent Register
Max expiry date:
12.7.2031Expiry date:
12.7.2016
Title:
OXAZINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS
Timeline
Today
13.7.2011EP application
16.10.2013EP Publication
6.1.2014Translation submitted
15.1.2014Registration published
12.7.2016Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
BADIGER, SangameshAddress:
Bangalore, IN
Name:
CHEBROLU, MuraliAddress:
Bangalore, IN
Name:
FREDERIKSEN, MathiasAddress:
Basel, CH
Name:
HOLZER, PhilippAddress:
Basel, CH
Name:
HURTH, KonstanzeAddress:
Basel, CH
Name:
LI, LeiAddress:
ChangshuJiangsu, CN
Name:
LIU, HuiAddress:
ChangshuJiangsu, CN
Name:
LUEOEND, Rainer MartinAddress:
Basel, CH
Name:
MACHAUER, RainerAddress:
Basel, CH
Name:
MOEBITZ, HenrikAddress:
Basel, CH
Name:
NEUMANN, UlfAddress:
Basel, CH
Name:
RAMOS, RitaAddress:
Basel, CH
Name:
RUEEGER, HeinrichAddress:
Basel, CH
Name:
SCHAEFER, MichaelAddress:
Basel, CH
Name:
TINTELNOT-BLOMLEY, MarinaAddress:
Basel, CH
Name:
VEENSTRA, Siem JacobAddress:
Basel, CH
Name:
VOEGTLE, MarkusAddress:
Basel, CH
Name:
XIONG, XinAddress:
ChangshuJiangsu, CN
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201161435088 PDate:
21.1.2011Country:
US
Number:
201161432058 PDate:
12.1.2011Country:
US
Number:
PCT/EP2010/060718Date:
23.7.2010Country:
WO
Number:
201061363702 PDate:
13.7.2010Country:
US
Classification
Categories:
C07D 265/30, C07D 413/12, C07D 417/12, C07D 471/04, C07D 487/04, A61K 31/5377, A61K 31/553, A61P 25/00, A61P 9/00, C07D 413/14
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 10.6.2014
Expires: 12.7.2015
Payer: Árnason Faktor
Number: 5
Paid: 9.6.2015
Expires: 12.7.2016
Payer: Árnason Faktor